Multiplier AI Blog
Know How Data, AI, & Digital Marketing Can Help Pharma & Life Sciences
How to Monitor Competitor Brand Launches Before They Happen: An AI Approach
Monitor pharma competitor launch AI strategies exist because, in pharma, a competitor launch is not a surprise event. It is the result of years of clinical development, regulatory work, and commercial preparation. Yet despite this long timeline, many organizations still find themselves reacting rather than preparing.
Pharma Competitive Intelligence in the Age of AI: From Quarterly Reports to Real-Time Signals
Competitive intelligence has always been a critical function in pharma. Understanding what competitors are doing, how markets are shifting, and where opportunities exist has a direct impact on commercial success.
Patient-Centric vs HCP-Centric Omnichannel: Why You Need Both and How They Connect
The False Choice That Limits Most Pharma StrategiesThe debate over patient-centric vs HCP-centric omnichannel pharma engagement has shaped how most companies allocate budgets, build teams, and design campaigns. Some teams emphasize healthcare professionals as the primary audience, while others advocate for a more patient-focused approach.
The Rise of AI-Generated Pharma Content: Compliance, Quality, and What MLR Teams Need to Know
In most pharma organizations today, the biggest constraint is no longer data or distribution. It is content — and this is exactly where AI-generated pharma content is changing the equation. Teams have more channels than ever: email, field engagement, digital platforms, mobile messaging, and virtual interactions are all available, and the ability to reach healthcare professionals has expanded si
Omnichannel HCP Engagement for Specialty Pharma: A Different Set of Rules
Most omnichannel strategies in pharma are built with scale in mind. They assume large HCP bases, broad segmentation, and high-volume outreach across multiple channels. This approach can work reasonably well for primary care therapies where reach and frequency are important.
Pharma Omnichannel on a Mid-Size Budget: A Practical Playbook for Growth
The myth that omnichannel requires enterprise budgets. There is a common belief in the pharma industry that true omnichannel engagement is only achievable for large organizations with extensive resources.
Graph Databases in Pharma: Mapping Physician Networks and Identifying Influencers
Pharma teams often know individual doctors, but they may not understand how those doctors are connected. Graph databases solve this gap by mapping physician relationships, research collaborations, institutional networks, and influence pathways across the healthcare ecosystem.
Real Time Physician Intelligence Platforms for Pharma Commercial Teams
Pharma commercial teams do not only need more doctor data. They need real-time physician intelligence that shows what HCPs are doing now, what they are interested in, and when engagement is most relevant.
Predicting Physician Engagement Using Machine Learning in Pharma
Pharma companies do not just need to know which doctors exist in their database. They need to know which physicians are likely to engage, when they are likely to respond, and what type of communication will create value. Machine learning makes this prediction possible. Pharmaceutical companies are increasingly using machine learning to predict physician engagement in pharma as communication cha
AI Omnichannel HCP Engagement Platform in Pharma: Complete Guide
Most pharma companies already use multiple engagement channels. The real challenge is that those channels rarely work together. An AI omnichannel HCP engagement platform solves this by connecting physician data,
What Is the Next Best Action in Pharma Commercial Operations? A Practical Guide
Pharmaceutical commercial teams interact with healthcare professionals through many channels. Sales representatives conduct in person meetings with physicians. Marketing teams send digital communications such as email campaigns and educational content.
AI for KOL Identification in Pharma: How to Find Influential Physicians
Finding the right KOL is no longer about knowing the most famous doctor in a therapy area. In modern pharma, the real challenge is identifying which physicians truly influence research, clinical practice, peer networks, and treatment adoption. AI is making this process faster, deeper, and more objective.